Bio-Reign Luxe™ is an innovative, bioactive, bioresorbable synthetic bone graft putty designed to support natural bone remodeling. Engineered using cutting-edge biomaterial science, Bio-Reign Luxe™ provides an optimal environment for osteointegration and enhanced osteocyte formation.
Bioactive & Bioresorbable
Unique Interconnected Porosity
Customizable & Easy to Use
Reduced Infection Risk
Sterile composition minimizes infection risk compared to traditional grafts.
Eliminates Donor Site Morbidity
Bio-Reign Luxe™ Consists of:
Silica-induced Bi-phase Calcium Phosphate Ceramic Granules
80%
Hydroxyapatite (HA)
20%
Beta-Tricalcium Phosphate (β-TCP)
Overall Porosity of 75-80%
MICROSPACES (1-10 M):
Stimulate cell attachment and growth.
MIDIPORES (1O-100 M):
Support osteocyte accommodation and proliferation.
MACROPORES (> 100 M):
Facilitate penetration of osteogenic cells and vascular structures.
Proven Performance
Stability
Innovation
Ordering Information
| Code | Size | Description |
|---|---|---|
| BRL-1 | 1.0cc | 1.0cc syringe pre-hydrated |
| BRL-3 | 3.0cc | 3.0cc syringe |
| BRL-5 | 5.0cc | 5.0cc syringe |
| BRL-10 | 10.0cc | 10.0cc syringe pre-hydrated |
Explore our Entire Product Line
Autologous Advanced Biologics
Advanced Synthetics
About Royal
Royal is a pioneering leader in orthobiologic and wound care research and development. Royal’s commitment lies in delivering top-tier, innovative biologic solutions that enhance the healing process and improve patients' quality of life. Royal places patient well-being at the center of its mission, offering exceptional solutions to address a variety of complex needs.
At Royal, our mission is driven by patient-centered care, innovation and excellence, and integrity and compassion. Royal provides a comprehensive array of products tailored to meet the varied needs of the orthobiologic and wound care industry.
As a rapidly expanding force in the industry, Royal is continuously developing and launching new products and solutions that set benchmarks for quality, effectiveness, and patient outcomes. Royal’s commitment to research and innovation keeps it at the forefront of the industry, helping to shape the future of healthcare and improving lives.
